Paragon Capital Management »

Halozyme Therapeutics shares owned by Paragon Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Paragon Capital Management from 13F filings

Historical chart of Paragon Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Paragon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Paragon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 19k 67.30

More positions owned by Paragon Capital Management

Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr Trust Ishare 0-1 (SHV)
Spdr Series Trust State Street Spd (BIL)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr Us Treas Bd Etf (GOVT)
Ssga Active Etf Tr State Street Dou (TOTL)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Total Stk Mkt (VTI)
Ssga Active Tr State Street Dou (STOT)
Meta Platforms Cl A (META)
O'reilly Automotive (ORLY)
Booking Holdings (BKNG)
IDEXX Laboratories (IDXX)
MercadoLibre (MELI)

View all positions for Paragon Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics